Effect of mycobacteriophage to intracellular mycobateria in vitro

Chinese Medical Journal

Volumn 119, Issue 8, 2006, Pages 692-695

  Peng, Li ^a   Chen, Bao Wen ^b   Luo, Yong Ai ^a   Wang, Guo Zhi ^b  

^a CHONGQING MEDICAL UNIVERSITY   (China)

^b NATIONAL INSTITUTE FOR THE CONTROL OF PHARMACEUTICAL AND BIOLOGICAL PRODUCTS   (China)

Author keywords

Infection; Macrophage; Mycobacteriophage D29; Mycobacterium; Phagocyte

Indexed keywords

ANALYSIS OF VARIANCE; ANIMAL CELL; ARTICLE; BACTERIAL CELL; BACTERIOPHAGE; BACTERIUM CULTURE; CONTROLLED STUDY; FEMALE; IN VITRO STUDY; INTRACELLULAR SPACE; MOUSE; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; MYCOBACTERIUM SMEGMATIS; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PERITONEUM MACROPHAGE; VIRUS REPLICATION; ANIMAL; BAGG ALBINO MOUSE; ELECTRON MICROSCOPY; MACROPHAGE; MICROBIOLOGY; MYCOBACTERIOPHAGE; PHYSIOLOGY; VIROLOGY;

ANIMALS; FEMALE; MACROPHAGES; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; MYCOBACTERIOPHAGES; MYCOBACTERIUM TUBERCULOSIS; VIRUS REPLICATION;

EID: 33646833410     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.1097/00029330-200604020-00014     Document Type: Article

References (15)

1. Fuller KJ, Hetfull GF. Mycobacteriophage L5 in infection of mycobacterium bovis BCG: implications for phage genetics in the slow-growing mycobacteria. Mol Microbiol 1997; 26: 755-766.
2. Wilson SM, al-Suwaidi Z, McNemy R, Porter J, Drobniewski F. Evaluation of a new rapid bacteriophage-based method for the drug susceptibility testing of mycobacterium tuberculosis. Net Med 1997; 3: 465-468.
3. Ford ME, Sarkis GJ, Belanger AE, Hendrix RW, Hatfull GF. Genome structure of mycobacteriophage D29: implication for phage evolution. J Mol Biol 1998; 279:143-164.
4. Pena CE, Stoner J, Hatfull GF. Mycobacteriophage D29 integrase-mediated recombination, specificity of mycobacteriophage integration. Gene 1998; 225: 143-151.
5. Foley-Thomas EM, Whipple DL, Bermudez LE, Barletta RG. Phage infection, transfection and transformation of Mycobaterium avium complex and Mycobacterium paratuberlosis. Microbiology 1995; 141: 1173-1181.
6. Broxmeyer L, Sosnowska D, Miltner E, Chancon O, Wagner D, McGarvey J, et al. Killing of Mycobacterium avium and Mycobacterium tuberculosis by a mycobateriophage delivered by a nonvirulent mycobacterium: a model for phage therapy of intracellular bacterial pathogens. J Infect Dis 2002; 186:1155-1166.
7. Dannenberg AM Jr. Pathogenesis of pulmonary tuberculosis. Am Rev Respir Dis 1982; 125:25-30.
8. Bermudez LE, Parker A, Goodman JR. Growth within macrophages increases the efficiency of mycobacterium avium in invading other macrophages by a complemenr receptor-independent pathway. Infect Immune 1997; 65: 1916-1925.
9. Eltringham IJ, Wilson SM, Drobnieski FA. Evaluation of a bacteriophage-based assay (phage amplified biologically assay) as a rapid screen for rapid screen for resistance to isoniazid, ethambutol, streptomycin, pyrazinamide and ciprofloxacin among clinical isolates of mycobacterium tuberculosis. J Clin Microbiol 1999; 37: 3528-3532.
10. Guo RQ, Zhu RQ, Separation and purification of mice celiac macrophage. J Chongqing Med Univ (Chin) 1991; 16:157-159.
11. Bermudez LE, Stevens P, Kolonoski P, Wu M, Young LS. Treatment of experimental disseminated Mycobacterium avium complex infection in mice with recombinant IL-2 and tumor necrosis factor. J Immunol 1989; 9:2996-3000.
12. Crowle AJ, Tsang AY, Vatter AE, May MH. Comparison of L5 laboratory and patient-derived strains of Mycobacterium avium for ability to infect and multiply in cultured human macrophages. J Clin Microbiol 1986; 24: 812-821.
13. Alexander S, Zemphira A, Morris GJ. Bcteriophage therapy. Antimicrobiol Agents Chemther 2000; 45: 649-659.
14. Sula L, Sulova J, Stolcpartova M. Therapy of experimental tuberculosis in guinea pigs with mycobacterial phages DS-6A, GR-21, My-327. Czech Med 1981; 4: 209-214.
15. Ford ME, Stenstrom C, Hendrix RW, Hatfull GF. Mycobacteriophage TM4: genome structure and expression. Tuberc Lung Dis 1998; 79: 63-73.